PATENT CLAIM ANALYSIS

Application Number: 15908387
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "021100"]

Abstract:
The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

Claim (Index 3):
The method of  claim 1 , wherein the combination is administered at the time of diagnosis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.575
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15348253', '14831469', '14831100', '15584499', '15584795']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8038166467749748
- 35 USC 102 Novelty (BERT): 0.5501062747357489
- Combined Prediction Score: 0.7784456095710522
- Mean Citation Score: 325.727164
- Max Citation Score: 401.47208
- Similarity Product: 398.8014647713328

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test